Perampanel for the Reduction of Seizure Frequency in Patients With High-grade Glioma and Focal Epilepsy
Conditions: Intractable Epilepsy; Malignant Glioma; Seizure Disorder Interventions: Drug: Phenobarbital, Phenytoin, Carbamazepine, Valproate, Gabapentin, Pregabalin, Lamotrigine, Topiramate, Leviteracetam, Lacosamide, Zonisamide, Clobazam, Oxcarbezepine, Rufinamide; Drug: Perampanel; Other: Quality-of-Life Assessment; Other: Questionnaire Administration Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Brain Tumor | Cancer & Oncology | Carbamazepine | Epilepsy | Gabapentin | Glioma | Inovelon | Lamictal | Lyrica | Neurontin | Phenobarbital | Phenytoin | Research | Rufinamide | Topamax